Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses

Journal of Hepatology

Volumn 53, Issue 5, 2010, Pages 805-816

  Pelletier, Sandy ^a,c   Drouin, Christian ^a,c   Bédard, Nathalie ^a   Khakoo, Salim I ^b   Bruneau, Julie ^a,c   Shoukry, Naglaa H ^a,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cytokines; Cytotoxicity; Innate immunity; Viral hepatitis

Indexed keywords

GAMMA INTERFERON; NATURAL KILLER CELL RECEPTOR NKG2A;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; VIRUS REPLICATION;

ACUTE DISEASE; ADAPTIVE IMMUNITY; ADULT; CELL DEGRANULATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; T-LYMPHOCYTES; VIRAL LOAD;

EID: 77957336301     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.05.013     Document Type: Article

References (49)

1. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 36 2002 S21 S29
2. L.B. Dustin, and C.M. Rice Flying under the radar: the immunobiology of hepatitis C Annu Rev Immunol 25 2007 71 99
3. N.H. Shoukry, A.G. Cawthon, and C.M. Walker Cell-mediated immunity and the outcome of hepatitis C virus infection Annu Rev Microbiol 58 2004 391 424
4. M.A. Cooper, T.A. Fehniger, and M.A. Caligiuri The biology of human natural killer-cell subsets Trends Immunol 22 2001 633 640
5. M.A. Degli-Esposti, and M.J. Smyth Close encounters of different kinds: dendritic cells and NK cells take centre stage Nat Rev Immunol 5 2005 112 124
6. L. Moretta, G. Ferlazzo, C. Bottino, M. Vitale, D. Pende, and M.C. Mingari Effector and regulatory events during natural killer-dendritic cell interactions Immunol Rev 214 2006 219 228
7. G. Ferlazzo, M.L. Tsang, L. Moretta, G. Melioli, R.M. Steinman, and C. Munz Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells J Exp Med 195 2002 343 351
8. M. Vitale, M. Della Chiesa, S. Carlomagno, D. Pende, M. Arico, and L. Moretta NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor Blood 106 2005 566 571
9. D. Piccioli, S. Sbrana, E. Melandri, and N.M. Valiante Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells J Exp Med 195 2002 335 341
10. S. Crotta, A. Stilla, A. Wack, A. D'Andrea, S. Nuti, and U. D'Oro Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein J Exp Med 195 2002 35 41
11. C.T. Tseng, and G.R. Klimpel Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions J Exp Med 195 2002 43 49
12. J.C. Yoon, M. Shiina, G. Ahlenstiel, and B. Rehermann Natural killer cell function is intact after direct exposure to infectious hepatitis C virions Hepatology 49 2009 12 21
13. S.I. Khakoo, C.L. Thio, M.P. Martin, C.R. Brooks, X. Gao, and J. Astemborski HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 305 2004 872 874
14. V. Romero, J. Azocar, J. Zuniga, O.P. Clavijo, D. Terreros, and X. Gu Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis C virus infection outcome Mol Immunol 45 2008 2429 2436
15. L. Golden-Mason, L. Madrigal-Estebas, E. McGrath, M.J. Conroy, E.J. Ryan, and J.E. Hegarty Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure Gut 57 2008 1121 1128
16. G. Borsellino, M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, and R. Giometto Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression Blood 110 2007 1225 1232
17. C. Morishima, D.M. Paschal, C.C. Wang, C.S. Yoshihara, B.L. Wood, and A.E. Yeo Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing Hepatology 43 2006 573 580
18. J. Nattermann, G. Feldmann, G. Ahlenstiel, B. Langhans, T. Sauerbruch, and U. Spengler Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C Gut 55 2006 869 877
19. U.C. Meier, R.E. Owen, E. Taylor, A. Worth, N. Naoumov, and C. Willberg Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections J Virol 79 2005 12365 12374
20. J. Corado, F. Toro, H. Rivera, N.E. Bianco, L. Deibis, and J.B. De Sanctis Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection Clin Exp Immunol 109 1997 451 457
21. A.L. Cox, K. Page, J. Bruneau, N.H. Shoukry, G.M. Lauer, and A.Y. Kim Rare birds in North America: acute hepatitis C cohorts Gastroenterology 136 2009 26 31
22. M. Sherman, S. Shafran, K. Burak, K. Doucette, W. Wong, and N. Girgrah Management of chronic hepatitis C: consensus guidelines Can J Gastroenterol 21 2007 25C 34C (Pubitemid 47177083)
23. + memory T cells J Virol 82 2008 10017 10031
24. G. Alter, J.M. Malenfant, R.M. Delabre, N.C. Burgett, X.G. Yu, and M. Lichterfeld Increased natural killer cell activity in viremic HIV-1 infection J Immunol 173 2004 5305 5311
25. R. Vallejo, O. de Leon-Casasola, and R. Benyamin Opioid therapy and immunosuppression: a review Am J Ther 11 2004 354 365
26. D.M. Novick, M. Ochshorn, V. Ghali, T.S. Croxson, W.D. Mercer, and N. Chiorazzi Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients J Pharmacol Exp Ther 250 1989 606 610
27. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection J Virol 71 1997 6011 6019
28. G.M. Lauer, E. Barnes, M. Lucas, J. Timm, K. Ouchi, and A.Y. Kim High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection Gastroenterology 127 2004 924 936
29. + T-cell responses in acute hepatitis C virus infection and early therapy J Virol 79 2005 12979 12988
30. S. Smyk-Pearson, I.A. Tester, D. Lezotte, A.W. Sasaki, D.M. Lewinsohn, and H.R. Rosen Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design J Infect Dis 194 2006 454 463
31. M.J. Robertson, M.A. Caligiuri, T.J. Manley, H. Levine, and J. Ritz Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis J Immunol 145 1990 3194 3201
32. M.A. Caligiuri Human natural killer cells Blood 112 2008 461 469
33. - killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation J Immunol 178 2007 4947 4955
34. T. Deignan, M.P. Curry, D.G. Doherty, L. Golden-Mason, Y. Volkov, and S. Norris Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection J Hepatol 37 2002 101 108
35. J. Boisvert, E.J. Kunkel, J.J. Campbell, E.B. Keeffe, E.C. Butcher, and H.B. Greenberg Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes J Hepatol 38 2003 67 75
36. N. Kawarabayashi, S. Seki, K. Hatsuse, T. Ohkawa, Y. Koike, and T. Aihara Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma Hepatology 32 2000 962 969
37. B. Oliviero, S. Varchetta, E. Paudice, G. Michelone, M. Zaramella, and D. Mavilio Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 137 2009 1151 1160
38. G. Ahlenstiel, R.H. Titerence, C. Koh, B. Edlich, J.J. Feld, and Y. Rotman Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-α-dependent manner Gastroenterology 138 2010 325 335
39. H. Friedman, C. Newton, and T.W. Klein Microbial infections, immunomodulation, and drugs of abuse Clin Microbiol Rev 16 2003 209 219
40. K.E. Ugen, and S.B. Nyland Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy Springer Semin Immunopathol 28 2006 281 287
41. J. Wang, R.A. Barke, J. Ma, R. Charboneau, and S. Roy Opiate abuse, innate immunity, and bacterial infectious diseases Arch Immunol Ther Exp (Warsz) 56 2008 299 309
42. A. De Maria, M. Fogli, S. Mazza, M. Basso, A. Picciotto, and P. Costa Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients Eur J Immunol 37 2007 445 455
43. P. Bonorino, M. Ramzan, X. Camous, T. Dufeu-Duchesne, M.A. Thelu, and N. Sturm Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C J Hepatol 51 2009 458 467
44. M. Jinushi, T. Takehara, T. Tatsumi, T. Kanto, T. Miyagi, and T. Suzuki Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection J Immunol 173 2004 6072 6081
45. G. Alter, J.M. Malenfant, and M. Altfeld CD107a as a functional marker for the identification of natural killer cell activity J Immunol Methods 294 2004 15 22 (Pubitemid 39626587)
46. P. Krebs, M.J. Barnes, K. Lampe, K. Whitley, K.S. Bahjat, and B. Beutler NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses Blood 113 2009 6593 6602
47. C.E. Andoniou, S.L. van Dommelen, V. Voigt, D.M. Andrews, G. Brizard, and C. Asselin-Paturel Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity Nat Immunol 6 2005 1011 1019
48. I.N. Crispe, M. Giannandrea, I. Klein, B. John, B. Sampson, and S. Wuensch Cellular and molecular mechanisms of liver tolerance Immunol Rev 213 2006 101 118
49. I.N. Crispe The liver as a lymphoid organ Annu Rev Immunol 27 2009 147 163